{"id":979832,"date":"2026-07-08T16:04:06","date_gmt":"2026-07-08T20:04:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/"},"modified":"2026-07-08T16:04:06","modified_gmt":"2026-07-08T20:04:06","slug":"spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/","title":{"rendered":"Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position:inside }\n.bwalignl { text-align: left }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit<\/b><\/p>\n<p>SOUTH SAN FRANCISCO, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fsprucebio.com%2F&amp;esheet=54567244&amp;newsitemid=20260708053762&amp;lan=en-US&amp;anchor=Spruce+Biosciences%2C+Inc.&amp;index=133&amp;md5=fc5f8b2d2229a3c8cc5d30fc89d600da\">Spruce Biosciences, Inc.<\/a> (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit, in a fireside chat hosted by Madison El-Saadi, Ph.D., Healthcare Research Analyst.<\/p>\n<p>The B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit will take place on July 16, 2026, at the InterContinental Boston hotel in Boston, MA.<\/p>\n<p>Participation in the summit is by invitation only. Investors interested in scheduling an in-person meeting with the Spruce management team should contact their B. Riley Securities representative or email <a rel=\"nofollow\" href=\"mailto:healthcareevents@brileysecurities.com\">healthcareevents@brileysecurities.com<\/a>.<\/p>\n<p><b>About Spruce Biosciences<\/b><\/p>\n<p>Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need. Spruce\u2019s lead product candidate, tralesinidase alfa enzyme replacement therapy (TA-ERT), is in late-stage development for the treatment of mucopolysaccharidoses type IIIB (MPS IIIB), or Sanfilippo Syndrome Type B, a devastating pediatric neurodegenerative disorder for which there are no FDA-approved therapies. TA-ERT has received Breakthrough Therapy Designation, Rare Pediatric Disease Designation, Fast Track Designation and Orphan Drug Designation from the FDA, as well as Orphan Drug Designation in the European Union. To learn more, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sprucebio.com&amp;esheet=54567244&amp;newsitemid=20260708053762&amp;lan=en-US&amp;anchor=www.sprucebio.com&amp;index=134&amp;md5=ba44ad100f2b09eade3f6ab3e9bb96c3\">www.sprucebio.com<\/a> and follow us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FSpruce_Bio&amp;esheet=54567244&amp;newsitemid=20260708053762&amp;lan=en-US&amp;anchor=X&amp;index=135&amp;md5=7312dc7c37ead99aa5d01afab99fe6f4\">X<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fspruce-biosciences&amp;esheet=54567244&amp;newsitemid=20260708053762&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=136&amp;md5=97964601de6137ab25c2982eb285ba06\">LinkedIn<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FSpruceBio&amp;esheet=54567244&amp;newsitemid=20260708053762&amp;lan=en-US&amp;anchor=Facebook&amp;index=137&amp;md5=b1d0f140288c0d2ece9b480db4183c9e\">Facebook<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2F%40sprucebiosciences&amp;esheet=54567244&amp;newsitemid=20260708053762&amp;lan=en-US&amp;anchor=YouTube&amp;index=138&amp;md5=460cfdcd7013090f5a7d5e31d46172f4\">YouTube<\/a>.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260708053762r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260708053762\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260708053762\/en\/<\/a><\/span><\/p>\n<p class=\"bwalignl\"><b>Media<\/b><br \/>Carolyn Hawley<br \/>Inizio Evoke Comms<br \/><a rel=\"nofollow\" href=\"mailto:Carolyn.Hawley@inizioevoke.com\">Carolyn.Hawley@inizioevoke.com<\/a><br \/><a rel=\"nofollow\" href=\"mailto:media@sprucebio.com\">media@sprucebio.com<\/a><\/p>\n<p><b>Investors<\/b><br \/>Monique Kosse<br \/>Gilmartin Group<br \/><a rel=\"nofollow\" href=\"mailto:Monique@GilmartinIR.com\">Monique@GilmartinIR.com<\/a><br \/><a rel=\"nofollow\" href=\"mailto:investors@sprucebio.com\">investors@sprucebio.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> California Massachusetts United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Consumer Neurology Children Clinical Trials Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260708053762\/en\/2847842\/3\/SB_Logo_Short_Color_Large.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211;Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit, in a fireside chat hosted by Madison El-Saadi, Ph.D., Healthcare Research Analyst. The B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit will take place on July 16, 2026, at the InterContinental Boston hotel in Boston, MA. Participation in the summit is by invitation only. Investors interested in scheduling an in-person &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-979832","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211;Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit, in a fireside chat hosted by Madison El-Saadi, Ph.D., Healthcare Research Analyst. The B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit will take place on July 16, 2026, at the InterContinental Boston hotel in Boston, MA. Participation in the summit is by invitation only. Investors interested in scheduling an in-person &hellip; Continue reading &quot;Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-08T20:04:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260708053762r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit\",\"datePublished\":\"2026-07-08T20:04:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\\\/\"},\"wordCount\":321,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260708053762r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\\\/\",\"name\":\"Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260708053762r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-07-08T20:04:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260708053762r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260708053762r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/","og_locale":"en_US","og_type":"article","og_title":"Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit - Market Newsdesk","og_description":"Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211;Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit, in a fireside chat hosted by Madison El-Saadi, Ph.D., Healthcare Research Analyst. The B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit will take place on July 16, 2026, at the InterContinental Boston hotel in Boston, MA. Participation in the summit is by invitation only. Investors interested in scheduling an in-person &hellip; Continue reading \"Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-08T20:04:06+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260708053762r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit","datePublished":"2026-07-08T20:04:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/"},"wordCount":321,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260708053762r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/","name":"Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260708053762r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-07-08T20:04:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260708053762r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260708053762r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-participate-in-the-b-riley-securities-2026-mind-muscle-vision-healthcare-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle &amp; Vision Healthcare Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/979832","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=979832"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/979832\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=979832"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=979832"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=979832"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}